☰

Agnieszka Nikiforuk, PhD - Publications

Affiliations: 
Behavioral Neuroscience Institute of Pharmacology, Polish Academy of Sciences 
Area:
neuroscience, behavioral neuropharmacology, rodent behavior, animal models of psychiatric disorders, cognitive
Tree Info Grants Similar researchers PubMed Report error

91 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Popik P, Cyrano E, Piotrowska D, Holuj M, Golebiowska J, Malikowska-Racia N, Potasiewicz A, Nikiforuk A. Effects of ketamine on rat social behavior as analyzed by DeepLabCut and SimBA deep learning algorithms. Frontiers in Pharmacology. 14: 1329424. PMID 38269275 DOI: 10.3389/fphar.2023.1329424  0.793
2023 Piotrowska D, Potasiewicz A, Popik P, Nikiforuk A. Pro-social and pro-cognitive effects of LIT-001, a novel oxytocin receptor agonist in a neurodevelopmental model of schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 78: 30-42. PMID 37866191 DOI: 10.1016/j.euroneuro.2023.09.005  0.837
2023 Gzieło K, Piotrowska D, Litwa E, Popik P, Nikiforuk A. Maternal immune activation affects socio-communicative behavior in adult rats. Scientific Reports. 13: 1918. PMID 36732579 DOI: 10.1038/s41598-023-28919-z  0.798
2022 Malikowska-Racia N, Golebiowska J, Nikiforuk A, Khoo SY, Popik P. Effects of ketamine optical isomers, fluoxetine and naloxone on timing in differential reinforcement of low-rate response (DRL) 72-s task in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 67: 37-52. PMID 36476352 DOI: 10.1016/j.euroneuro.2022.11.007  0.792
2022 Gzielo K, Nikiforuk A. The Effects of Positive Allosteric Modulators of α7-nAChR on Social Play Behavior in Adolescent Rats Prenatally Exposed to Valproic Acid. Pharmaceuticals (Basel, Switzerland). 15. PMID 36422547 DOI: 10.3390/ph15111417  0.805
2022 Salamon D, Zapała B, Krawczyk A, Potasiewicz A, Nikiforuk A, Stój A, Gosiewski T. Comparison of iSeq and MiSeq as the two platforms for 16S rRNA sequencing in the study of the gut of rat microbiome. Applied Microbiology and Biotechnology. 106: 7671-7681. PMID 36322250 DOI: 10.1007/s00253-022-12251-z  0.67
2022 Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N, Nikiforuk A, Golebiowska J. Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats. Psychopharmacology. PMID 35234983 DOI: 10.1007/s00213-021-06020-5  0.796
2021 Gzielo K, Nikiforuk A. Astroglia in Autism Spectrum Disorder. International Journal of Molecular Sciences. 22. PMID 34768975 DOI: 10.3390/ijms222111544  0.742
2021 Zajdel P, Grychowska K, Mogilski S, Kurczab R, Satała G, Bugno R, Kos T, Gołębiowska J, Malikowska-Racia N, Nikiforuk A, Chaumont-Dubel S, Bantreil X, Pawłowski M, Martinez J, Subra G, et al. Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT and 5-HT Receptor Antagonist with Antipsychotic and Procognitive Properties. Journal of Medicinal Chemistry. PMID 34467765 DOI: 10.1021/acs.jmedchem.1c00224  0.813
2021 Potasiewicz A, Faron-Gorecka A, Popik P, Nikiforuk A. Repeated treatment with alpha 7 nicotinic acetylcholine receptor ligands enhances cognitive processes and stimulates Erk1/2 and Arc genes in rats. Behavioural Brain Research. 409: 113338. PMID 33940049 DOI: 10.1016/j.bbr.2021.113338  0.804
2021 Gzielo K, Potasiewicz A, Litwa E, Piotrowska D, Popik P, Nikiforuk A. The Effect of Maternal Immune Activation on Social Play-Induced Ultrasonic Vocalization in Rats. Brain Sciences. 11. PMID 33803154 DOI: 10.3390/brainsci11030344  0.802
2021 Drop M, Canale V, Chaumont-Dubel S, Kurczab R, Satała G, Bantreil X, Walczak M, Koczurkiewicz-Adamczyk P, Latacz G, Gwizdak A, Krawczyk M, Gołębiowska J, Grychowska K, Bojarski AJ, Nikiforuk A, et al. 2-Phenyl-1-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT Receptor Inverse Agonists with Cognition-Enhancing Activity. Acs Chemical Neuroscience. PMID 33705101 DOI: 10.1021/acschemneuro.1c00061  0.623
2021 Zaniewska M, Nikiforuk A, Głowacka U, Brygider S, Wesołowska J, Litwa E, Maćkowiak M. Chronic Lorcaserin Treatment Reverses the Nicotine Withdrawal-Induced Disruptions to Behavior and Maturation in Developing Neurons in the Hippocampus of Rats. International Journal of Molecular Sciences. 22. PMID 33467149 DOI: 10.3390/ijms22020868  0.351
2020 Haduch A, Pukło R, Alenina N, Nikiforuk A, Popik P, Bader M, Daniel WA. The effect of ageing and cerebral serotonin deficit on the activity of cytochrome P450 2D (CYP2D) in the brain and liver of male rats. Neurochemistry International. 141: 104884. PMID 33091481 DOI: 10.1016/j.neuint.2020.104884  0.55
2020 Gzielo K, Potasiewicz A, Hołuj M, Litwa E, Popik P, Nikiforuk A. Valproic acid exposure impairs ultrasonic communication in infant, adolescent and adult rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 32978035 DOI: 10.1016/j.euroneuro.2020.09.006  0.792
2020 Popik P, Khoo SY, Kuziak A, Golebiowska J, Potasiewicz A, Hogendorf A, Popik O, Matloka M, Moszczynski R, Nikiforuk A, Witkin JM. Distinct cognitive and discriminative stimulus effects of ketamine enantiomers in rats. Pharmacology, Biochemistry, and Behavior. 173011. PMID 32758523 DOI: 10.1016/J.Pbb.2020.173011  0.777
2020 Potasiewicz A, Gzielo K, Popik P, Nikiforuk A. Effects of prenatal exposure to valproic acid or poly(I:C) on ultrasonic vocalizations in rat pups: the role of social cues. Physiology & Behavior. 113113. PMID 32738314 DOI: 10.1016/J.Physbeh.2020.113113  0.797
2020 Nikiforuk A, Litwa E, Krawczyk M, Popik P, Arias H. Correction to: Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats. Pharmacological Reports : Pr. 72: 1078. PMID 32642944 DOI: 10.1007/s43440-020-00128-9  0.628
2020 Nikiforuk A, Litwa E, Krawczyk M, Popik P, Arias H. Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats. Pharmacological Reports : Pr. PMID 32207091 DOI: 10.1007/S43440-020-00092-4  0.653
2020 Potasiewicz A, Holuj M, Litwa E, Gzielo K, Socha L, Popik P, Nikiforuk A. Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies. Neuropharmacology. 170: 108040. PMID 32165218 DOI: 10.1016/J.Neuropharm.2020.108040  0.819
2020 Potasiewicz A, Krawczyk M, Gzielo K, Popik P, Nikiforuk A. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors enhance procognitive effects of conventional anti-Alzheimer drugs in scopolamine-treated rats. Behavioural Brain Research. 112547. PMID 32087183 DOI: 10.1016/J.Bbr.2020.112547  0.821
2019 Golebiowska J, Hołuj M, Potasiewicz A, Piotrowska D, Kuziak A, Popik P, Homberg JR, Nikiforuk A. Serotonin transporter deficiency alters socioemotional ultrasonic communication in rats. Scientific Reports. 9: 20283. PMID 31889084 DOI: 10.1038/S41598-019-56629-Y  0.811
2019 Popik P, Krawczyk M, Kuziak A, Bugno R, Hogendorf A, Staroń J, Nikiforuk A. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats. Journal of Psychopharmacology (Oxford, England). 269881119867603. PMID 31452444 DOI: 10.1177/0269881119867603  0.636
2019 Hogendorf AS, Hogendorf A, Kurczab R, Kalinowska-Tłuścik J, Popik P, Nikiforuk A, Krawczyk M, Satała G, Lenda T, Knutelska J, Bugno R, Staroń J, Pietruś W, Matłoka M, Dubiel K, et al. 2-Aminoimidazole-based antagonists of the 5-HT receptor - A new concept in aminergic GPCR ligand design. European Journal of Medicinal Chemistry. 179: 1-15. PMID 31229883 DOI: 10.1016/J.Ejmech.2019.06.001  0.613
2019 Gołębiowska J, Nikiforuk A, Alenina N, Bader M, Popik P. Effects of genetic deficiency of tryptophan hydroxylase 2 on attentional processes in the five choice serial reaction time task in rats European Neuropsychopharmacology. 29: S506-S507. DOI: 10.1016/J.Euroneuro.2018.11.754  0.571
2019 Nikiforuk A, Potasiewicz A, Arias H, Popik P. Activation of the alpha4 beta2 nicotinic acetylcholine receptor facilitates set-shifting performance in rats European Neuropsychopharmacology. 29: S270-S271. DOI: 10.1016/J.Euroneuro.2018.11.429  0.789
2019 Holuj M, Potasiewicz A, Wojcik M, Nikiforuk A, Popik P. Effects of prenatal exposure to methylazoxymethanol acetate on juvenile social play behavior and ultrasonic communication in male and female rats European Neuropsychopharmacology. 29: S251-S252. DOI: 10.1016/J.Euroneuro.2018.11.399  0.792
2018 Potasiewicz A, Golebiowska J, Popik P, Nikiforuk A. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors. Journal of Psychopharmacology (Oxford, England). 269881118812097. PMID 30501536 DOI: 10.1177/0269881118812097  0.811
2018 Potasiewicz A, Holuj M, Piotrowska D, Zajda K, Wojcik M, Popik P, Nikiforuk A. Evaluation of ultrasonic vocalizations in a neurodevelopmental model of schizophrenia during the early life stages of rats. Neuropharmacology. PMID 30448422 DOI: 10.1016/J.Neuropharm.2018.11.023  0.805
2018 Nikiforuk A. Assessment of cognitive functions in animal models of schizophrenia. Pharmacological Reports : Pr. 70: 639-649. PMID 29894866 DOI: 10.1016/J.Pharep.2018.01.009  0.438
2018 Zajdel P, Kos T, Marciniec K, Satała G, Canale V, Kamiński K, Hołuj M, Lenda T, Koralewski R, Bednarski M, Nowiński L, Wójcikowski J, Daniel WA, Nikiforuk A, Nalepa I, et al. Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects. European Journal of Medicinal Chemistry. 145: 790-804. PMID 29407591 DOI: 10.1016/J.Ejmech.2018.01.002  0.831
2017 Nikiforuk A, Kalaba P, Ilic M, Korz V, Dragačević V, Wackerlig J, Langer T, Höger H, Golebiowska J, Popik P, Lubec G. A Novel Dopamine Transporter Inhibitor CE-123 Improves Cognitive Flexibility and Maintains Impulsivity in Healthy Male Rats. Frontiers in Behavioral Neuroscience. 11: 222. PMID 29230168 DOI: 10.3389/Fnbeh.2017.00222  0.668
2017 Koola MM, Sklar J, Davis W, Nikiforuk A, Meissen JK, Sawant-Basak A, Aaronson ST, Kozak R. Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments. Schizophrenia Research. PMID 28705532 DOI: 10.1016/J.Schres.2017.07.005  0.402
2017 Zurawek D, Salerno-Kochan A, Dziedzicka-Wasylewska M, Nikiforuk A, Kos T, Popik P. Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia. Schizophrenia Research. PMID 28433499 DOI: 10.1016/J.Schres.2017.04.014  0.74
2017 Potasiewicz A, Nikiforuk A, Hołuj M, Popik P. Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats. Journal of Psychopharmacology (Oxford, England). 31: 260-271. PMID 28168926 DOI: 10.1177/0269881116675509  0.833
2016 Potasiewicz A, Hołuj M, Kos T, Popik P, Arias HR, Nikiforuk A. 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats. Neuropharmacology. PMID 27717880 DOI: 10.1016/J.Neuropharm.2016.10.002  0.841
2016 Nikiforuk A, Potasiewicz A, Kos T, Popik P. The combination of memantine and galantamine improves cognition in rats: the synergistic role of the α7 nicotinic acetylcholine and NMDA receptors. Behavioural Brain Research. PMID 27435422 DOI: 10.1016/J.Bbr.2016.07.023  0.83
2016 Nikiforuk A, Hołuj M, Kos T, Popik P. The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia. Neuropharmacology. PMID 26826431 DOI: 10.1016/J.Neuropharm.2016.01.035  0.857
2016 Nikiforuk A. Serotonergic and cholinergic strategies as potential targets for the treatment of schizophrenia. Current Pharmaceutical Design. PMID 26818861 DOI: 10.2174/1381612822666160127113758  0.451
2015 Nikiforuk A, Potasiewicz A, Rafa D, Drescher K, Bespalov A, Popik P. The effects of PDE10 inhibition on attentional set-shifting do not depend on the activation of dopamine D1 receptors. Behavioural Pharmacology. PMID 26580130 DOI: 10.1097/Fbp.0000000000000201  0.813
2015 Potasiewicz A, Kos T, Ravazzini F, Puia G, Arias HR, Popik P, Nikiforuk A. Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor. British Journal of Pharmacology. 172: 5123-35. PMID 26276349 DOI: 10.1111/Bph.13277  0.819
2015 Nikiforuk A, Kos T, Hołuj M, Potasiewicz A, Popik P. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats. Neuropharmacology. 101: 389-400. PMID 26232639 DOI: 10.1016/J.Neuropharm.2015.07.034  0.835
2015 Popik P, Nikiforuk A. Attentional Set-Shifting Paradigm in the Rat. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. 72: 9.51.1-9.51.13. PMID 26131663 DOI: 10.1002/0471142301.Ns0951S72  0.624
2015 Nikiforuk A, Kos T, Potasiewicz A, Popik P. Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1300-13. PMID 26003081 DOI: 10.1016/J.Euroneuro.2015.04.018  0.839
2015 Nikiforuk A, Hołuj M, Potasiewicz A, Popik P. Effects of the selective 5-HT7 receptor antagonist SB-269970 on premature responding in the five-choice serial reaction time test in rats. Behavioural Brain Research. 289: 149-56. PMID 25930219 DOI: 10.1016/J.Bbr.2015.04.030  0.837
2015 Ho?uj M, Popik P, Nikiforuk A. Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors. Behavioural Pharmacology. PMID 25769091 DOI: 10.1097/Fbp.0000000000000132  0.681
2015 Nikiforuk A. Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date. Cns Drugs. 29: 265-75. PMID 25721336 DOI: 10.1007/S40263-015-0236-0  0.408
2015 Popik P, Holuj M, Nikiforuk A, Kos T, Trullas R, Skolnick P. 1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats. Psychopharmacology. 232: 1025-38. PMID 25260339 DOI: 10.1007/S00213-014-3738-4  0.843
2015 Nikiforuk A, Kos T, Potasiewicz A, Popik P. Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats European Neuropsychopharmacology. 25: 1300-1313. DOI: 10.1016/j.euroneuro.2015.04.018  0.822
2015 Nikiforuk A, Hołuj M, Potasiewicz A, Popik P. Effects of the selective 5-HT7 receptor antagonist SB-269970 on premature responding in the five-choice serial reaction time test in rats Behavioural Brain Research. 289: 149-156. DOI: 10.1016/j.bbr.2015.04.030  0.811
2014 Rygula R, Szczech E, Papciak J, Nikiforuk A, Popik P. The effects of cocaine and mazindol on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm. Behavioural Brain Research. 270: 206-12. PMID 24859175 DOI: 10.1016/J.Bbr.2014.05.026  0.589
2014 Nikiforuk A, Popik P. The effects of acute and repeated administration of ketamine on attentional performance in the five-choice serial reaction time task in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1381-93. PMID 24846536 DOI: 10.1016/J.Euroneuro.2014.04.007  0.671
2014 Nikiforuk A. The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia. Reviews in the Neurosciences. 25: 367-82. PMID 24501158 DOI: 10.1515/revneuro-2014-0005  0.408
2014 Nikiforuk A, Popik P. Ketamine prevents stress-induced cognitive inflexibility in rats. Psychoneuroendocrinology. 40: 119-22. PMID 24485483 DOI: 10.1016/J.Psyneuen.2013.11.009  0.65
2014 Popik P, Kos T, Pluta H, Nikiforuk A, Rojek K, RyguÅ‚a R. Inhibition of the glucocorticoid synthesis reverses stress-induced decrease in rat's 50-kHz ultrasonic vocalizations. Behavioural Brain Research. 260: 53-7. PMID 24308957 DOI: 10.1016/J.Bbr.2013.11.029  0.707
2014 FijaÅ‚ K, Popik P, Nikiforuk A. Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats. Psychopharmacology. 231: 269-81. PMID 23954911 DOI: 10.1007/S00213-013-3234-2  0.656
2013 Nikiforuk A, Popik P. Neurochemical modulation of stress-induced cognitive inflexibility in a rat model of an attentional set-shifting task. Pharmacological Reports : Pr. 65: 1479-88. PMID 24552995 DOI: 10.1016/S1734-1140(13)71508-1  0.585
2013 Nikiforuk A, Kos T, FijaÅ‚ K, HoÅ‚uj M, Rafa D, Popik P. Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. Plos One. 8: e66695. PMID 23776692 DOI: 10.1371/Journal.Pone.0066695  0.847
2013 Nikiforuk A, Popik P. Amisulpride promotes cognitive flexibility in rats: the role of 5-HT7 receptors. Behavioural Brain Research. 248: 136-40. PMID 23603557 DOI: 10.1016/J.Bbr.2013.04.008  0.696
2013 Nikiforuk A, FijaÅ‚ K, Potasiewicz A, Popik P, Kos T. The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats. Journal of Psychopharmacology (Oxford, England). 27: 469-76. PMID 23479455 DOI: 10.1177/0269881113480991  0.844
2013 Nikiforuk A. Quetiapine ameliorates stress-induced cognitive inflexibility in rats. Neuropharmacology. 64: 357-64. PMID 22750412 DOI: 10.1016/J.Neuropharm.2012.06.042  0.473
2013 Potasiewicz A, Nikiforuk A, Popik P. P.2.024 The effects of positive allosteric modulators of α7 nicotinic receptors on rats' performance in the odour span test European Neuropsychopharmacology. 23: S46. DOI: 10.1016/S0924-977X(13)70052-X  0.806
2013 Rafa D, Nikiforuk A, Popik P. P.2.023 The antagonist of 5-HT7 receptors, SB-269970, and amisulpride both reverse ketamine-induced cognitive inflexibility in rats European Neuropsychopharmacology. 23: S45. DOI: 10.1016/S0924-977X(13)70051-8  0.831
2012 Nikiforuk A. Dopamine D1 receptor modulation of set shifting: the role of stress exposure. Behavioural Pharmacology. 23: 434-8. PMID 22743605 DOI: 10.1097/Fbp.0B013E328356522F  0.439
2012 Nikiforuk A. Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats. Behavioural Brain Research. 226: 118-23. PMID 21925545 DOI: 10.1016/J.Bbr.2011.09.006  0.512
2012 Nikiforuk A, Popik P. Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats. Psychopharmacology. 220: 65-74. PMID 21918808 DOI: 10.1007/S00213-011-2487-X  0.688
2012 Rafa D, Nikiforuk A. P.1.g.001 The 5-HT6 receptor agonist EMD 386088 promotes cognitive flexibility in rats European Neuropsychopharmacology. 22: S205-S206. DOI: 10.1016/S0924-977X(12)70298-5  0.825
2012 Nikiforuk A. Poster #11 THE EFFECTS OF THE DOPAMINE D1 RECEPTOR AGONISTON ATTENTIONAL SET-SHIFTING TASK PERFORMANCE IN RATS Schizophrenia Research. 136: S284. DOI: 10.1016/S0920-9964(12)70844-7  0.404
2011 Nikiforuk A, Kos T, Rafa D, Behl B, Bespalov A, Popik P. Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner. Neuropharmacology. 61: 262-7. PMID 21530555 DOI: 10.1016/J.Neuropharm.2011.04.010  0.825
2011 Nikiforuk A, Kos T, WesoÅ‚owska A. The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration. Psychopharmacology. 217: 411-8. PMID 21499701 DOI: 10.1007/S00213-011-2297-1  0.665
2011 Kos T, Nikiforuk A, Rafa D, Popik P. The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice. Psychopharmacology. 214: 911-21. PMID 21161188 DOI: 10.1007/S00213-010-2102-6  0.817
2011 Nikiforuk A, Popik P. Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants. Psychoneuroendocrinology. 36: 28-39. PMID 20580164 DOI: 10.1016/J.Psyneuen.2010.06.001  0.636
2011 Nikiforuk A, Popik P. P.1.g.006 A selective blockade of 5-HT7 receptors promotes cognitive flexibility in rats European Neuropsychopharmacology. 21: S332. DOI: 10.1016/S0924-977X(11)70527-2  0.621
2010 Nikiforuk A, Popik P, Drescher KU, van Gaalen M, Relo AL, Mezler M, Marek G, Schoemaker H, Gross G, Bespalov A. Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats. The Journal of Pharmacology and Experimental Therapeutics. 335: 665-73. PMID 20739457 DOI: 10.1124/Jpet.110.170506  0.687
2010 Nikiforuk A, GoÅ‚embiowska K, Popik P. Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 37-48. PMID 19729284 DOI: 10.1016/J.Euroneuro.2009.08.001  0.691
2009 Nikiforuk A, Popik P. Antidepressants alleviate the impact of reinforcer downshift. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 41-8. PMID 18805678 DOI: 10.1016/J.Euroneuro.2008.08.002  0.578
2009 Stachowicz K, Nikiforuk A, Wieronska J, Chojnacka-Wójcik E, Pilc A. P.2.25 Anxiolytic-like effects of LY487379 an allosteric modulator of mGlu2 receptors in rats European Neuropsychopharmacology. 19: S54-S55. DOI: 10.1016/S0924-977X(09)70063-X  0.435
2008 WesoÅ‚owska A, Nikiforuk A. The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats. European Journal of Pharmacology. 582: 88-93. PMID 18234190 DOI: 10.1016/J.Ejphar.2007.12.013  0.461
2008 Nikiforuk A, Popik P. P.1.d.002 The effect of chlordiazepoxide on reward reduction-induced decrease of operant performance European Neuropsychopharmacology. 18: S249-S250. DOI: 10.1016/S0924-977X(08)70317-1  0.471
2007 Paluchowska MH, Bugno R, DuszyÅ„ska B, TatarczyÅ„ska E, Nikiforuk A, Lenda T, Chojnacka-Wójcik E. The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines. Bioorganic & Medicinal Chemistry. 15: 7116-25. PMID 17825569 DOI: 10.1016/J.Bmc.2007.07.029  0.378
2007 WesoÅ‚owska A, Nikiforuk A, Stachowicz K. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats. Behavioural Pharmacology. 18: 439-46. PMID 17762512 DOI: 10.1097/Fbp.0B013E3282D28F9C  0.456
2007 ChÅ‚oÅ„-Rzepa G, Zmudzki P, Zajdel P, Bojarski AJ, DuszyÅ„ska B, Nikiforuk A, TatarczyÅ„ska E, PawÅ‚owski M. 7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT(1A), 5-HT(2A), and 5-HT(7) serotonin receptor ligands. Bioorganic & Medicinal Chemistry. 15: 5239-50. PMID 17517514 DOI: 10.1016/J.Bmc.2007.05.017  0.357
2007 Basile AS, Janowsky A, Golembiowska K, Kowalska M, Tam E, Benveniste M, Popik P, Nikiforuk A, Krawczyk M, Nowak G, Krieter PA, Lippa AS, Skolnick P, Koustova E. Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain. The Journal of Pharmacology and Experimental Therapeutics. 321: 1208-25. PMID 17325229 DOI: 10.1124/Jpet.106.116483  0.632
2007 Zajdel P, Subra G, Bojarski AJ, DuszyÅ„ska B, TatarczyÅ„ska E, Nikiforuk A, Chojnacka-Wójcik E, PawÅ‚owski M, Martinez J. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation. Bioorganic & Medicinal Chemistry. 15: 2907-19. PMID 17321139 DOI: 10.1016/J.Bmc.2007.02.018  0.351
2007 WesoÅ‚owska A, Nikiforuk A. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology. 52: 1274-83. PMID 17320917 DOI: 10.1016/J.Neuropharm.2007.01.007  0.401
2007 WesoÅ‚owska A, TatarczyÅ„ska E, Nikiforuk A, Chojnacka-Wójcik E. Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice. European Journal of Pharmacology. 555: 43-7. PMID 17109856 DOI: 10.1016/J.Ejphar.2006.10.001  0.391
2007 Stachowicz K, Wesolowska A, Nikiforuk A, Chojnacka-Wójcik E. P.2.01 Effect of the 5-HT6 receptor antagonist in animal models of anxiety and depression after intrahippocampal administration European Neuropsychopharmacology. 17: S40-S41. DOI: 10.1016/S0924-977X(07)70046-9  0.373
2006 WesoÅ‚owska A, Nikiforuk A, Stachowicz K. Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. European Journal of Pharmacology. 553: 185-90. PMID 17097082 DOI: 10.1016/J.Ejphar.2006.09.064  0.452
2006 WesoÅ‚owska A, Nikiforuk A, Stachowicz K, TatarczyÅ„ska E. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology. 51: 578-86. PMID 16828124 DOI: 10.1016/J.Neuropharm.2006.04.017  0.425
2006 WesoÅ‚owska A, Nikiforuk A, Chojnacka-Wójcik E. Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice. European Journal of Pharmacology. 541: 57-63. PMID 16765343 DOI: 10.1016/J.Ejphar.2006.04.049  0.412
2006 Wesolowska A, Nikiforuk A, Stachowicz K, Chojnacka-Wojcik E. P.1.d.004 Effects of a selective and brain penetrating 5-HT6 receptor antagonist in animal models of depression and anxiety European Neuropsychopharmacology. 16: S251-S252. DOI: 10.1016/S0924-977X(06)70221-8  0.358
Show low-probability matches.